SCIENCE 37 HOLDINGS, INC. Stock-Based Compensation
SCIENCE 37 HOLDINGS, INC. reported Stock-Based Compensation of $12.29 million for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-07.
Discontinued › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2023-11-07
- SCIENCE 37 HOLDINGS, INC. share-based payment arrangement, noncash expense for the quarter ending 2023-09-30 was $3.58M, a 37.66% decline year-over-year.
- SCIENCE 37 HOLDINGS, INC. share-based payment arrangement, noncash expense for the quarter ending 2023-06-30 was $3.60M, a 41.26% decline year-over-year.
- SCIENCE 37 HOLDINGS, INC. share-based payment arrangement, noncash expense for the quarter ending 2023-03-31 was $5.11M, a 32.41% decline year-over-year.
- SCIENCE 37 HOLDINGS, INC. share-based payment arrangement, noncash expense for the quarter ending 2022-12-31 was $5.14M, a 20.90% decline year-over-year.
- SCIENCE 37 HOLDINGS, INC. share-based payment arrangement, noncash expense for fiscal 2022 was $24.56M, a 192.16% increase from fiscal 2021.
- SCIENCE 37 HOLDINGS, INC. share-based payment arrangement, noncash expense for fiscal 2021 was $8.41M, a 6790.98% increase from fiscal 2020.
- SCIENCE 37 HOLDINGS, INC. share-based payment arrangement, noncash expense for fiscal 2020 was $122.00K.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|
| 2023-09-30 | $3.58M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $7.18M derived: sum of 2 quarters · filed 2023-11-07 | $12.29M 10-Q · filed 2023-11-07 | $17.42M derived: sum of 4 quarters · filed 2023-11-07 |
| 2023-06-30 | $3.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $8.71M 10-Q · filed 2023-08-08 | $13.85M derived: sum of 3 quarters · filed 2023-08-08 | $19.58M derived: sum of 4 quarters · filed 2023-11-07 |
| 2023-03-31 | $5.11M 10-Q · filed 2023-05-15 | $10.24M derived: sum of 2 quarters · filed 2023-05-15 | $15.98M derived: sum of 3 quarters · filed 2023-11-07 | $22.11M derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-12-31 | $5.14M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | $10.88M derived: sum of 2 quarters · filed 2023-11-07 | $17.00M derived: sum of 3 quarters · filed 2023-11-07 | $24.56M 10-K · filed 2023-03-06 |
| 2022-09-30 | $5.74M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $11.87M derived: sum of 2 quarters · filed 2023-11-07 | $19.43M 10-Q · filed 2023-11-07 | $25.92M derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | $6.13M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $13.69M 10-Q · filed 2023-08-08 | $20.18M derived: sum of 3 quarters · filed 2023-08-08 | $21.18M derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-03-31 | $7.56M 10-Q · filed 2023-05-15 | $14.05M derived: sum of 2 quarters · filed 2023-05-15 | $15.05M derived: sum of 3 quarters · filed 2023-05-15 | $15.74M derived: sum of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | $6.49M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | $7.49M derived: sum of 2 quarters · filed 2023-03-06 | $8.18M derived: sum of 3 quarters · filed 2023-03-06 | $8.41M 10-K · filed 2023-03-06 |
| 2021-09-30 | $998.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $1.69M derived: sum of 2 quarters · filed 2022-11-10 | $1.91M 10-Q · filed 2022-11-10 | |
| 2021-06-30 | $690.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $915.00K 10-Q · filed 2022-08-11 | ||
| 2021-03-31 | $225.00K 10-Q · filed 2022-05-09 | |||
| 2020-12-31 | $122.00K 10-K · filed 2022-03-22 |